Back
Range Cancer Therapeutics ETF Vs. Virtus LifeSci Biotech Products ETF Industry Stock Comparison
Buy
63
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.58
Seasonality Move:
8.86%
Buy
68
BBP
Virtus LifeSci Biotech Products ETF
Last Price:
64.41
Seasonality Move:
7.78%
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.59. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Virtus LifeSci Biotech Products ETF (BBP)
is a Buy
Is Virtus LifeSci Biotech Products ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Products ETF [BBP] share price is $66.22. The Score for BBP is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- BBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.
BBP Stock Price Chart
What is Virtus LifeSci Biotech Products ETF's stock price today?
-
The Virtus LifeSci Biotech Products ETF share price today is $66.22
The current trend is moderately bullish and BBP is experiencing slight buying pressure.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 59.34 | Buy |
| Chaikin Money Flow: | -127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.63 - 15.23) | Buy |
| Bollinger Bands (100): | (14 - 15.38) | Buy |
BBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.6 | Buy |
| Relative Strength Index (14 RSI): | 65.45 | Buy |
| Chaikin Money Flow: | 144 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.14 - 64.44) | Buy |
| Bollinger Bands (100): | (60.15 - 64.21) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.03 | Buy |
| 20-day SMA: | 15 | Buy |
| 50-day SMA: | 15.01 | Buy |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 15.09 | Buy |
| 20-day EMA: | 15.01 | Buy |
| 50-day EMA: | 14.94 | Buy |
| 200-day EMA: | 14.59 | Buy |
BBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.56 | Buy |
| 20-day SMA: | 63.64 | Buy |
| 50-day SMA: | 63.2 | Buy |
| 200-day SMA: | 59.43 | Buy |
| 8-day EMA: | 64.61 | Buy |
| 20-day EMA: | 63.88 | Buy |
| 50-day EMA: | 63.11 | Buy |
| 200-day EMA: | 59.72 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Products ETF Earnings Growth & BBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Virtus LifeSci Biotech Products ETF Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||